Natural Treasures's Profile
Displaying 201-250 of 2820 result(s).
Go to page:
Recent Articles
- Aspocomp's Strong Performance in H1 2025: Revenue Growth
- Vitrolife AB's Remarkable Growth in Consumables for Q2
- Exploring ASSA ABLOY's Robust Q2 2025 Financial Performance
- Sivers Semiconductors Reports Strong Q2 2025 Financial Performance
- Vitrolife AB Sees Steady Growth Amid Currency Challenges
- ASSA ABLOY Q2 2025 Financial Results and Growth Highlights
- ASSA ABLOY Delivers Impressive Results Despite Challenges
- Operational Insights and Future Growth of Havila Kystruten AS
- Pharming Group Prepares to Share Business Performance Insights
- ICG Enterprise Trust Buys Back Shares Amid Market Conditions
- Equinor ASA Enhances Employee Participation Through Share Buy-Back
- Exploring the Splendid Design of Honka Kömmeli Log Homes
- Insights from AS Tallink Grupp's Upcoming Investor Webinar
- Explore AS Tallink Grupp's Upcoming Investor Webinar Insights
- Aspocomp Reports Strong Growth in Half-Year Results
- Nicox and Kowa Forge Major Collaboration in Glaucoma Care
- Aalberts N.V. Expands HVAC Solutions with Geo-Flo Acquisition
- Nvidia Surpasses Global economic Leaders in Stock Index
- Volvo Group Reports Adjustments Amid Stabilizing Markets
- Hansa Biopharma's Financial Updates: Q2 2025 Highlights
- GC Biopharma's BARYCELA Secures Marketing Authorization
- Reju Partners with Circle-8 for Sustainable Textile Recycling
- Reju and Circle-8 Join Forces to Revolutionize Textile Recycling
- Dev Technosys Recognized Among Premier Mobile App Developers
- Crown LNG Faces Over 55% Drop After Delisting Announcement
- Essity's Q2 2025 Report: Challenges and Growth Ambitions
- Volvo Cars Q2 2025 EBIT Report and Future Outlook on Growth
- Publicis Groupe's Financial Journey in H1 2025 Explained
- Volvo Group Reports Q2 2025 Financial Performance Insights
- Hansa Biopharma Shows Strong Financial Growth in Q2 2025
- EQT AB Reports Impressive Half-Year Performance Analysis
- Hansa Biopharma's Q2 Report: Growth and Future Prospects
- Publicis Groupe's Impressive Financial Performance in 2025
- Viridien Prepares for Q2 2025 Financial Results Announcement
- Nicox and Kowa Forge €191.5 Million Partnership for NCX 470
- Aalberts N.V.'s Strategic Acquisition of Geo-Flo Corporation
- Volvo Cars' Q2 2025 Results Showcase Positive Change
- Telenor Group Divests Allente Stake to Viaplay Group
- Opendoor's Stocks Surge on Exciting Activist Investor Moves
- Essity Reports Strong Performance Amid Economic Challenges
- Hexaware's Strategic Move to Enhance Global Capability Centers
- Essity Reports Positive Growth Amid Economic Challenges
- Verkkokauppa.com Oyj Reports Growth Amid Market Uncertainty
- Hexagon Purus Reports Drop in Q2 2025 Revenue and Outlook
- Sanofi Extends Tender Offer for Blueprint Medicines Shares
- Novartis Achieves Strong Q2 Growth with Enhanced Guidance for 2025
- EfTEN United Property Fund Shows Steady Growth and Performance
- TGS Reports Second Quarter 2025 Financial Performance Insights
- TGS ASA Declares Quarterly Dividend for Third Quarter 2025
- Mukul Mehta Takes Helm as CFO of Novartis Amid Leadership Shift
